Subscribe

1999 Indications of Steinberg for Starting and Continuing Hydroxyurea Therapy in a Patient with Sickle Cell Disease

Specialty:

Hematology Oncology
Clinical Laboratory
Genetics

Objective:

ICD-10:

Description:

Hydroxyurea may have a number of beneficial effects in patients with sickle cell disease. It can result in an increase in hemoglobin F concentration and reduce neutrophils, monocytes and reticulocytes. Its use may be limited by the development of unacceptable myelotoxicity or by a failure to show improvement.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone